Therma Bright Inc. (TSXV:THRM)

Market Cap	3.06M -10.8%
Revenue (ttm)	135.82K +343.5%
Net Income	-4.01M
EPS	-0.07
Shares Out	61.25M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.0500
Previous Close	0.0500
Day's Range	0.0450 - 0.0500
52-Week Range	0.0400 - 0.1200
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About Therma Bright

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: THRM

Financial Performance

In fiscal year 2025, Therma Bright's revenue was 75,228, an increase of 1150.67% compared to the previous year's 6,015. Losses were -4.34 million, 77.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error